We are live on ! Find out more
XBIT icon

XBiotech

34 hedge funds and large institutions have $4.22M invested in XBiotech in 2026 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.19% less ownership

Funds ownership: 6.5% → 6.32% (-0.19%)

8% less funds holding

Funds holding: 37 → 34 (-3)

29% less capital inflows, than outflows

Capital inflows: $250K | Capital outflows: $351K

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $44K

Holders
34
Holders Change
-3
Holders Change %
-8.11%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
9
Closed
4
Calls
–
Puts
$44​K
Net Calls
-⁠$44​K
Net Calls Change
-⁠$174​K

XBIT Hedge Fund Activity: Q3 2026 in Review

34 of the 8,208 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q3 2026, worth a combined $4.22M — down 7.6% from $4.56M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of XBIT and 2 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 6 added.

The largest buyer was Allworth Financial, opening a new position worth an estimated $78.4K. The largest seller was Citadel Advisors, exiting entirely with an estimated $67.1K sold.

  • 34 institutional investors held XBiotech (XBIT) as of Q3 2026, down from 37 in Q2 2026.
  • Funds reported $4.22M of XBiotech stock for Q3 2026, down 7.6% quarter-over-quarter.
  • 2 funds opened new XBiotech positions in Q3 2026 and 4 closed out, a net change of -2 holders.
  • The largest XBiotech buyer in Q3 2026 was Allworth Financial, an estimated $78.4K added.
  • The largest XBiotech seller in Q3 2026 was Citadel Advisors, an estimated $67.1K sold.

Based on aggregated 13F filings for Q3 2026.